Clinical Trial Update: Saroglitazar Magnesium for Treatment of Primary Biliary Cholangitis [Phase 2, Phase 3]

View source ↗

Summary

Clinical trial update indicating completion of Phase 2 and Phase 3 studies evaluating saroglitazar magnesium for Primary Biliary Cholangitis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Biliary Cholangitis

Drugs mentioned

• Saroglitazar Magnesium (saroglitazar magnesium)

Snippet

Sponsor: Zydus Therapeutics Inc. | Conditions: Primary Biliary Cholangitis | Phase 2, Phase 3 | Status: COMPLETED